Gabon vs Germany: HIV/AIDS deaths averted by antiretroviral therapy
Gabon
2,398 deaths
in 2024
Germany
2,906 deaths
in 2024
Gabon rank
53rd
Germany rank
51st
HIV/AIDS deaths averted by antiretroviral therapy over time
- Gabon
- Germany
How they compare
Germany currently reports 2,906 deaths against 2,398 deaths in Gabon, a difference of 508 deaths.
That makes Germany's figure about 1.2 times Gabon's.
Across all 35 years both countries report, Germany has been ahead every year.
Gabon ranks 53rd and Germany ranks 51st of 157 countries.
Germany has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Gabon | Germany | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 1,195 deaths | 1,195 deaths | Germany |
| 2000s | 658.44 deaths | 2,173 deaths | 1,514 deaths | Germany |
| 2010s | 2,011 deaths | 2,484 deaths | 472.26 deaths | Germany |
| 2020s | 2,106 deaths | 2,825 deaths | 719.03 deaths | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Gabon or Germany?
- Germany, at 2,906 deaths against 2,398 deaths in Gabon as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Gabon and Germany?
- 508 deaths, with Germany ahead.
- How many years of comparable data are there for Gabon and Germany?
- 35 years are reported by both, from 1990 to 2024.
- How do Gabon and Germany rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Gabon ranks 53rd and Germany ranks 51st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.